Cancer Treatment Analysis
🇪🇺 EMAExpert commentary and market intelligence for pharma strategy teams
Showing 1–4 of 4 articles
Earlier
Medium impact AnalysisMay 30, 2026
Pfizer's Talzenna Combo: A Game Changer in Prostate Cancer Treatment
prostate cancer · 2 min
Dr. Elena RossiStandard impact AnalysisMay 2, 2026
NICE Technology Appraisals: Impact on Market Access for Novel Oncology Drugs
NICE · oncology · 11 min
Hiroshi SatoStandard impact AnalysisApr 29, 2026
HTA Outcomes Oncology Therapies: G-BA vs NICE Post-Brexit Analysis
G-BA, NICE · oncology · 10 min
Dr. Elena RossiMedium impact AnalysisApr 20, 2026
CAR-T Therapies Cost-Effectiveness: EU HTA Bodies' Divergent Assessments
EMA · oncology · 10 min
Dr. Elena RossiExplore intelligence